TOTALENERGIES 72.210 € (-1,15 %)
SOITEC 124.700 € (-3,07 %)
KERING 264.900 € (-0,17 %)
ROBERTET 812.000 € (-1,46 %)
SHELL PLC 35.110 € (-1,10 %)
AEGON 7.468 € (-0,27 %)
ENGIE 26.960 € (+0,22 %)
BASIC-FIT 31.800 € (-0,81 %)
EIFFAGE 130.250 € (+0,70 %)
AYVENS 11.900 € (-1,41 %)
EUTELSAT COMMUNIC. 2.554 € (-1,39 %)
WOLTERS KLUWER 59.800 € (-0,23 %)
LEGRAND 145.000 € (+4,54 %)
FLOW TRADERS 25.940 € (+0,39 %)
ABIVAX 88.300 € (+5,69 %)
ESSILORLUXOTTICA 174.750 € (-4,79 %)
ATOS 36.400 € (-0,66 %)
ASML HOLDING 1 656.400 € (+4,10 %)
BOIRON 27.500 € (-0,72 %)
AXA 42.530 € (+0,43 %)
ADYEN 888.300 € (-0,22 %)
THX PHARMA 3.720 € (-5,58 %)
AKZO NOBEL 59.000 € (+0,68 %)
GETLINK SE 18.570 € (+0,05 %)
VINCI 130.300 € (+0,85 %)
UMG 18.630 € (+2,93 %)
FUGRO 11.350 € (+2,44 %)
APERAM 48.980 € (-2,33 %)
SMCP 5.145 € (-0,19 %)
NEXITY 7.800 € (+0,71 %)
SAFRAN 324.000 € (0,00 %)
PERNOD RICARD 62.520 € (-1,39 %)
MEDINCELL 24.640 € (-12,06 %)
MICHELIN 33.320 € (-1,24 %)
TIKEHAU CAPITAL 17.640 € (-1,89 %)
SANOFI 74.880 € (-1,03 %)
2CRSI 44.600 € (-2,58 %)
STMICROELECTRONICS 65.160 € (-0,79 %)
CBI 0.109 € (+6,86 %)
RELX 28.360 € (+0,93 %)
S.E.B. 53.100 € (-2,75 %)
LVMH 511.000 € (-1,79 %)
DASSAULT SYSTEMES 17.315 € (-0,29 %)
ASM INTERNATIONAL 1 046.000 € (+5,89 %)
GL EVENTS 32.950 € (-0,90 %)
AMG 36.700 € (+2,86 %)
CHRISTIAN DIOR 474.400 € (-1,33 %)
GECINA 73.500 € (-1,01 %)
X-FAB 9.580 € (-2,15 %)
AHOLD DEL 35.390 € (-2,26 %)
AIRBUS 187.020 € (+0,93 %)
STELLANTIS NV 5.781 € (-3,21 %)
MEDIANTECHNOLOGIES 5.240 € (+2,75 %)
ACCOR 48.150 € (-0,72 %)
PLUXEE 11.380 € (+1,34 %)
CROSSJECT 1.896 € (-0,11 %)
ALTAREA 96.800 € (+0,31 %)
L'OREAL 382.150 € (-1,04 %)
INPOST 15.310 € (-0,07 %)
LHYFE 2.000 € (-0,99 %) |
10/02/2023 11:19
SARTORIUS AG: The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference shareEQS-News: SARTORIUS AG / Key word(s): Dividend The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share Göttingen, February 10, 2023. The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 29, 2023, to pay a dividend of 1.44 euros per preference share and 1.43 euros per ordinary share for fiscal 2022. Under this proposal, the total distributed profit would be 98.2 million euros. In the prior year, dividends were 1.26 euros per preference share and 1.25 euros per ordinary share.
This press release contains forward-looking statements about the future development of the Sartorius Group. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius assumes no liability for updating such statements in light of new information or future events.
Financial calendar
A profile of Sartorius The Sartorius Group is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the group’s Lab Products & Services division concentrates on serving the needs of laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies and those of academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The company is growing at double-digit rates on average per year and regularly expands its portfolio through the acquisition of complementary technologies. In fiscal 2022, the company generated sales revenues of around 4.2 billion euros. At the end of 2022, around 16,000 employees were working for customers around the globe at the group’s 60 or so production and sales sites.
Contact Philipp Grontzki Head of External Communications +49 (0)551.308.5581 philipp.grontzki@sartorius.com
10.02.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
1557281 10.02.2023 CET/CEST Source : Webdisclosure.com |
|||||||||||||||||||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière